Davita Inc

Article Abstract:

DaVita Inc.'s earnings should advance in 2003 and 2004 by 5% to 20-25% respectively. The company has a strong cash flow and repayment of debt is not yet due till 2006 but safety rank is below average and earnings predicatability only 5%, stock is suitbale for for risk-tolerant investorr.

Author: Chow, Nancy
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
Evaluation, Rankings

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

US Oncology

Article Abstract:

US Oncology which has invested in cancer care centers is expected to advance 15%-20% in share earnings by 2003 and 2004. Shares are ranked to outperform t he market .

Author: Chow, Nancy
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003
US Oncology Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Davita Inc

Article Abstract:

DaVita Inc. expects to have its earnings advance in 2003 and 2004. Shares are timely with above average appreciation potential out to 2006-2008.

Author: Chow, Nancy
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2003

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Finance, Health care industry, Company investment, Investments, Statistics, Securities, Company sales and earnings, Company earnings/profit, Company securities, Company business forecast/projection, Company forecasts, DaVita Inc.
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.